GYRE vs MNDY · rev $53.5M vs P/E 32, rev $1.23B
Gyre Therapeutics Inc. (GYRE) versus Monday.Com Ltd (MNDY) — a side-by-side from cached financials, not a winner call.
Gyre Therapeutics Inc. (GYRE) is a biotechnology company listed on NASDAQ.
Monday.Com Ltd (MNDY) is a software - application company listed on US.
Latest reported GYRE revenue for 2026-06-30 was $53.5M. Net income was -$32.8M. GYRE currently screens at market cap $589.9M.
Latest reported MNDY revenue for 2025-12-31 was $1.23B. Net income was $118.7M. Revenue was up 26.7% from 2024-12-31 to 2025-12-31. MNDY currently screens at market cap $3.79B and trailing P/E 32.1.
GYRE currently screens at market cap $589.9M. MNDY currently screens at market cap $3.79B and trailing P/E 32.1.
Not investment advice. Open the GYRE and MNDY stock pages for the full models.
Not investment advice.